PNPLA3 and metabolic dysfunction-associated steatotic liver disease: To this point, despite the fact that PNPLA3 and TM6SF2 polymorphisms represent most commonly investigated lipid metabolism based host genetic variants in NAFLD, their potential influence in CHC mediated CLP is less defined.